Pricing

Fennec Pharmaceuticals Inc (FENC)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Rostislav C. Raykov
Employees:
10
PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
(919) 636-4530
    Formally known as:
  • Adherex Technologies Inc.
  • Adherex Technologies Inc.
  • Adherex Technologies, Inc. Ordinary
  • FENNEC PHARMACEUTICALS, INC.
Stock Split History
DateRatio
2005-08-02 1:5
2011-08-30 1:18
2014-09-05 1:3
Fennec Pharmaceuticals Inc. develops product candidates for use in the treatment of cancer in the U.S. Its lead product PEDMARK is a formulation of Sodium Thiosulfate that has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available